Comparative efficacy of Chinese herbal injections in patients with cardiogenic shock (CS): a systematic review and Bayesian network meta-analysis of randomized controlled trials
Conclusion: To summarize, this analysis discovered that, in terms of patients suffering from CS, CHIs + WM yielded significantly greater advantages than WM alone. Based on in-hospital mortality and the remaining outcomes, Sm performed excellently among all the involved CHIs.Systematic Review Registration: https://www.Crd.york.ac.uk/prospero/, identifier: CRD42022347053. (Source: Frontiers in Pharmacology)
Source: Frontiers in Pharmacology - February 27, 2024 Category: Drugs & Pharmacology Source Type: research
Invasive mechanical ventilation in cardiogenic shock complicating acute myocardial infarction: A contemporary Danish cohort analysis
Invasive mechanical ventilation (IMV) is widely used in patients with cardiogenic shock following acute myocardial infarction (AMICS), but evidence to guide practice remains sparse. We sought to evaluate trends in the rate of IMV utilization, applied settings, and short term-outcome of a contemporary cohort of AMICS patients treated with IMV according to out-of-hospital cardiac arrest (OHCA) at admission. (Source: International Journal of Cardiology)
Source: International Journal of Cardiology - February 27, 2024 Category: Cardiology Authors: Amalie Ling Povlsen, Ole Kristian Lerche Helgestad, Jakob Josiassen, Steffen Christensen, Henrik Frederiksen H øjgaard, Jesper Kjærgaard, Christian Hassager, Henrik Schmidt, Lisette Okkels Jensen, Lene Holmvang, Jacob Eifer Møller, Hanne Berg Ravn Source Type: research
Progress in the treatment of diabetic cardiomyopathy, a systematic review
Summary of treatment methods for diabetic cardiomyopathy. AbstractDiabetic cardiomyopathy (DCM) is a condition characterized by myocardial dysfunction that occurs in individuals with diabetes, in the absence of coronary artery disease, valve disease, and other conventional cardiovascular risk factors such as hypertension and dyslipidemia. It is considered a significant and consequential complication of diabetes in the field of cardiovascular medicine. The primary pathological manifestations include myocardial hypertrophy, myocardial fibrosis, and impaired ventricular function, which can lead to widespread myocardial necros...
Source: Pharmacology Research and Perspectives - February 26, 2024 Category: Drugs & Pharmacology Authors: Yiyi Shou,
Xingyu Li,
Quan Fang,
Aqiong Xie,
Yinghong Zhang,
Xinyan Fu,
Mingwei Wang,
Wenyan Gong,
Xingwei Zhang,
Dong Yang Tags: REVIEW Source Type: research
Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association
Circulation. 2024 Feb 26. doi: 10.1161/CIR.0000000000001214. Online ahead of print.ABSTRACTCardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies. Older adults have been largely excluded from analyses of therapeutic options in patients with cardiogenic shock. As a result, despite the association of advanced age with worse outcomes, focused strategies in the assess...
Source: Circulation - February 26, 2024 Category: Cardiology Authors: Vanessa Blumer Manreet K Kanwar Christopher F Barnett Jennifer A Cowger Abdulla A Damluji Maryjane Farr Sarah J Goodlin Jason N Katz Colleen K McIlvennan Shashank S Sinha Tracy Y Wang American Heart Association Cardiovascular Disease in Older Populations Source Type: research
Cardiogenic Shock in Older Adults: A Focus on Age-Associated Risks and Approach to Management: A Scientific Statement From the American Heart Association
Circulation. 2024 Feb 26. doi: 10.1161/CIR.0000000000001214. Online ahead of print.ABSTRACTCardiogenic shock continues to portend poor outcomes, conferring short-term mortality rates of 30% to 50% despite recent scientific advances. Age is a nonmodifiable risk factor for mortality in patients with cardiogenic shock and is often considered in the decision-making process for eligibility for various therapies. Older adults have been largely excluded from analyses of therapeutic options in patients with cardiogenic shock. As a result, despite the association of advanced age with worse outcomes, focused strategies in the assess...
Source: Circulation - February 26, 2024 Category: Cardiology Authors: Vanessa Blumer Manreet K Kanwar Christopher F Barnett Jennifer A Cowger Abdulla A Damluji Maryjane Farr Sarah J Goodlin Jason N Katz Colleen K McIlvennan Shashank S Sinha Tracy Y Wang American Heart Association Cardiovascular Disease in Older Populations Source Type: research
